Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 24648769)

1.

Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study.

Marukutira T, Huprikar S, Azie N, Quan SP, Meier-Kriesche HU, Horn DL.

HIV AIDS (Auckl). 2014 Mar 13;6:39-47. doi: 10.2147/HIV.S53910. eCollection 2014.

2.

The Prospective Antifungal Therapy Alliance(®) registry: A two-centre Canadian experience.

Haider S, Rotstein C, Horn D, Laverdiere M, Azie N.

Can J Infect Dis Med Microbiol. 2014 Spring;25(1):17-23.

3.

The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.

Azie N, Neofytos D, Pfaller M, Meier-Kriesche HU, Quan SP, Horn D.

Diagn Microbiol Infect Dis. 2012 Aug;73(4):293-300. doi: 10.1016/j.diagmicrobio.2012.06.012. Review.

PMID:
22789847
4.

Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.

Horn DL, Fishman JA, Steinbach WJ, Anaissie EJ, Marr KA, Olyaei AJ, Pfaller MA, Weiss MA, Webster KM, Neofytos D.

Diagn Microbiol Infect Dis. 2007 Dec;59(4):407-14. Epub 2007 Sep 20.

PMID:
17888614
5.

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K.

Clin Infect Dis. 2009 Feb 1;48(3):265-73. doi: 10.1086/595846. Erratum in: Clin Infect Dis. 2009 Mar 1;48(5):690.

6.

Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital.

Shen YZ, Qi TK, Ma JX, Jiang XY, Wang JR, Xu QN, Huang Q, Liu XN, Sun HQ, Lu HZ.

Mycoses. 2007 Nov;50(6):475-80.

PMID:
17944709
7.

Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS.

Davis JA, Horn DL, Marr KA, Fishman JA.

Transpl Infect Dis. 2009 Oct;11(5):432-7. doi: 10.1111/j.1399-3062.2009.00424.x. Epub 2009 Jul 22.

PMID:
19638005
8.

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.

Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039.

9.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
10.

Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization.

Delgado AC, de Jesus Pedro R, Aoki FH, Resende MR, Trabasso P, Colombo AL, de Oliveira MS, Mikami Y, Moretti ML.

Clin Microbiol Infect. 2009 Apr;15(4):364-71.

11.

Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.

Dankner WM, Lindsey JC, Levin MJ; Pediatric AIDS Clinical Trials Group Protocol Teams 051, 128, 138, 144, 152, 179, 190, 220, 240, 245, 254, 300 and 327.

Pediatr Infect Dis J. 2001 Jan;20(1):40-8.

PMID:
11176565
12.

Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia.

Horn D, Neofytos D, Fishman J, Steinbach W, Anaisie E, Marr KA, Pfaller M, Olyaei A.

Eur J Clin Microbiol Infect Dis. 2007 Dec;26(12):907-14.

PMID:
17899230
13.

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D.

Diagn Microbiol Infect Dis. 2012 Dec;74(4):323-31. doi: 10.1016/j.diagmicrobio.2012.10.003. Epub 2012 Oct 25. Review.

PMID:
23102556
14.

Current approaches to diagnosis and treatment of fungal infections in children infected with human immuno deficiency virus.

Müller FM, Groll AH, Walsh TJ.

Eur J Pediatr. 1999 Mar;158(3):187-99. Review.

PMID:
10094436
15.

Profile of candidiasis in HIV infected patients.

Anwar KP, Malik A, Subhan KH.

Iran J Microbiol. 2012 Dec;4(4):204-9.

16.

Fungal diagnosis: how do we do it and can we do better?

Perfect JR.

Curr Med Res Opin. 2013 Apr;29 Suppl 4:3-11. doi: 10.1185/03007995.2012.761134. Review.

PMID:
23621588
17.

Invasive fungal infections in Canada from 1992 to 1994.

Nicolle L, Rotstein C, Bourgault A, St-Germain G, Garber G; Canadian Infectious Diseases Society Invasive Fungal Registry.

Can J Infect Dis. 1998 Nov;9(6):347-52.

18.

Management of mycoses in surgical patients -- review of the literature.

Holzheimer RG, Dralle H.

Eur J Med Res. 2002 May 31;7(5):200-26. Review.

PMID:
12069912
19.

Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.

Goldman M, Zackin R, Fichtenbaum CJ, Skiest DJ, Koletar SL, Hafner R, Wheat LJ, Nyangweso PM, Yiannoutsos CT, Schnizlein-Bick CT, Owens S, Aberg JA; AIDS Clinical Trials Group A5038 Study Group.

Clin Infect Dis. 2004 May 15;38(10):1485-9. Epub 2004 Apr 28.

20.

Recent advances in cryptococcosis, candidiasis and coccidioidomycosis complicating HIV infection.

Kappe R, Levitz S, Harrison TS, Ruhnke M, Ampel NM, Just-Nübling G.

Med Mycol. 1998;36 Suppl 1:207-15. Review.

PMID:
9988509
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk